EBS - Emergent BioSolutions Inc.

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue488,782489,331404,466
Cost of Revenue131,284107,486101,963
Gross Profit357,498381,845302,503
Operating Expenses
Research Development108,290119,186104,721
Selling General and Administrative143,686121,145108,594
Non Recurring---
Total Operating Expenses---
Operating Income or Loss105,522141,51489,188
Income from Continuing Operations
Total Other Income/Expenses Net1,3167253,246
Earnings Before Interest and Taxes106,838142,23992,434
Interest Expense7,6176,5238,240
Income Before Tax99,221135,71684,194
Income Tax Expense36,69744,30029,928
Minority Interest---
Net Income From Continuing Ops62,52491,41654,266
Non-recurring Events
Discontinued Operations-10,748-28,546-17,525
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income51,77662,87036,741
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares51,77662,87036,741